Endoscopic submucosal dissection: evolving role and position in the management of Barrett's neoplasia.
暂无分享,去创建一个
[1] E. Schoon,et al. Extending treatment criteria for Barrett’s neoplasia: results of a nationwide cohort of 138 ESDs , 2021, Endoscopy.
[2] S. Friedland,et al. Endoscopic submucosal dissection is associated with less pathologic uncertainty than endoscopic mucosal resection in diagnosing and staging Barrett's‐related neoplasia , 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[3] G. Ginsberg,et al. Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. , 2020, Gastrointestinal endoscopy.
[4] Mohamed O. Othman,et al. Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection For Barrett's Esophagus and Colorectal Neoplasia , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] C. Hassan,et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement , 2017, Endoscopy.
[6] L. Gossner,et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. , 2014, Gastroenterology.
[7] F. T. ten Kate,et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens , 2010, Endoscopy.